A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

Completed · Not applicable

Conditions studied: Candidiasis, Esophageal, HIV Infections

In brief

The purpose of this study is to see if it is safe to give L-743,872 to men with candidal esophagitis, an AIDS-related yeast infection in the esophagus.

Key facts

Study ID

NCT00005921

Run by

Merck Sharp & Dohme LLC

People needed

18

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• You may be eligible for this study if you:
• Are an 18- to 65-year-old man with candidal esophagitis.

Where it is running

• Gary Calandra — Rahway, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.